Based on recent data, REGENXBIO Inc. (RGNX) shows an Average True Range (ATR) of 0.81 and an Enterprise Value of 840.61M. Its average trading volume over the past 3 months is 1.98M, indicating liquidity. These fundamental metrics provide insight into RGNX's underlying financial health and market activity.
| ATR | 0.81 |
| Enterprise Value | 840.61M |
| Avg Vol (3 Months) | 1.98M |
| Avg Vol (10 Days) | 2.2M |
REGENXBIO Inc. (RGNX) technical indicators as of August 30, 2026: the SMA 20 is -5.68%, SMA 50 at -28.4%, and SMA 200 at -17.22%. The RSI 14 value is 37.87, suggesting its current momentum. These technical analysis signals help assess RGNX's price trends and potential future movements.
| SMA 20 | -5.68% |
| SMA 50 | -28.4% |
| SMA 200 | -17.22% |
| RSI 14 | 37.87 |
REGENXBIO Inc. (RGNX) stock performance overview as of August 30, 2026: The 52-week high is $16.19 (currently -45.95% below), and the 52-week low is $5.46 (currently 73.78% above). Over the past year, RGNX's performance is 97.2%, compared to the S&P 500's 1.58% change.
| 52-Week High | 16.19 |
| 52-Week High Chg | -45.95% |
| 52-Week Low | 5.46 |
| 52-Week Low Chg | +73.78% |
| S&P 500 52-Week Chg | 1.58% |
According to market data, REGENXBIO Inc. (RGNX) stock's recent performance metrics show that over the last month, RGNX is 7.06%, with a Year-to-Date (YTD) performance of -2.08%. Over the past year, the stock has seen a 97.2% change. These figures summarize RGNX's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 10.1 | 12.08 | 15.88 | 15.88 | 16.19 | 16.19 |
| Low | 7.77 | 7.77 | 5.88 | 5.46 | 5.46 | 5.46 |
| Performance | -6.50% | +7.06% | +20.20% | +66.08% | +97.20% | -2.08% |
According to current financial data, RGNX stock's P/E (TTM) ratio is -2.55, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.25. Key valuation ratios for RGNX, including P/S (2.86), P/B (7.11), and P/FCF (-2.00), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | RGNX | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -2.55 | -1.25 | -194.36 | 32.59 |
| P/S (TTM) | 2.86 | 3.71 | 467.56 | 5.98 |
| P/B (TTM) | 7.11 | 1.35 | 16.73 | 5.89 |
| P/FCF (TTM) | -2 | -2.06 | -616.79 | 30.26 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep